Literature DB >> 34028757

A Rodent Model of Hypertrophic Scarring: Splinting of Rat Wounds.

Dong Ok Son1, Boris Hinz2.   

Abstract

Human hypertrophic scars are the result of imperfect healing of skin, which is particularly evident from the scars developing after severe burns. In contrast, mouse and rat full-thickness skin wounds heal normally without forming visible scar tissue, which reduces the suitability of rodent models for the study of skin scarring. We here provide a simple procedure to splint the edges of full-thickness rodent skin with a sutured plastic frame that prevents wound closure by granulation tissue contraction. The resulting mechanical tension in the wound bed and the lack of neo-epithelium amplify myofibroblast formation and generate hypertrophic features, not unlike those of human skin. In addition to producing scar tissue, the splint provides a reservoir that can be used for the delivery of cellular and acellular wound treatment regimen. Despite being simple and almost historical, wound splinting is a robust and reliable model to study myofibroblast biology.

Entities:  

Keywords:  Hypertrophic scarring; Mechanical stress; Myofibroblast; Splint; Stress fibers; Wound healing; α-Smooth muscle actin

Year:  2021        PMID: 34028757     DOI: 10.1007/978-1-0716-1382-5_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Wound contraction in rabbit skin, studied by splinting the wound margins.

Authors:  M ABERCROMBIE; D W JAMES; J F NEWCOMBE
Journal:  J Anat       Date:  1960-04       Impact factor: 2.610

Review 2.  The myofibroblast: paradigm for a mechanically active cell.

Authors:  Boris Hinz
Journal:  J Biomech       Date:  2009-10-03       Impact factor: 2.712

Review 3.  Scar and contracture: biological principles.

Authors:  Peter Kwan; Keijiro Hori; Jie Ding; Edward E Tredget
Journal:  Hand Clin       Date:  2009-11       Impact factor: 1.907

Review 4.  Mechanical regulation of myofibroblast phenoconversion and collagen contraction.

Authors:  Boris Hinz; Christopher A McCulloch; Nuno M Coelho
Journal:  Exp Cell Res       Date:  2019-03-22       Impact factor: 3.905

Review 5.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

Review 6.  Giulio Gabbiani and the discovery of myofibroblasts.

Authors:  Domenico Ribatti; Roberto Tamma
Journal:  Inflamm Res       Date:  2019-01-04       Impact factor: 4.575

7.  Experimental models for cutaneous hypertrophic scar research.

Authors:  Jialun Li; Jiecong Wang; Zhenxing Wang; Yun Xia; Muran Zhou; Aimei Zhong; Jiaming Sun
Journal:  Wound Repair Regen       Date:  2019-10-21       Impact factor: 3.617

8.  Hypertrophic Scarring in the Rabbit Ear: A Practical Model for Studying Dermal Fibrosis.

Authors:  Layla Nabai; Aziz Ghahary
Journal:  Methods Mol Biol       Date:  2017

Review 9.  Rat models of skin wound healing: a review.

Authors:  Wanda A Dorsett-Martin
Journal:  Wound Repair Regen       Date:  2004 Nov-Dec       Impact factor: 3.617

Review 10.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.

Authors:  Boris Hinz; David Lagares
Journal:  Nat Rev Rheumatol       Date:  2019-12-02       Impact factor: 20.543

View more
  3 in total

Review 1.  Experimental Models to Study Skin Wound Healing with a Focus on Angiogenesis.

Authors:  Eberhard Grambow; Heiko Sorg; Christian G G Sorg; Daniel Strüder
Journal:  Med Sci (Basel)       Date:  2021-08-25

Review 2.  Wound healing, fibroblast heterogeneity, and fibrosis.

Authors:  Heather E Talbott; Shamik Mascharak; Michelle Griffin; Derrick C Wan; Michael T Longaker
Journal:  Cell Stem Cell       Date:  2022-08-04       Impact factor: 25.269

Review 3.  In Vivo Models for Hypertrophic Scars-A Systematic Review.

Authors:  Stefan Rössler; Sebastian Philipp Nischwitz; Hanna Luze; Judith C J Holzer-Geissler; Robert Zrim; Lars-Peter Kamolz
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.